Accuracy of indocyanine green pulse spectrophotometry clearance test for liver function prediction in transplanted patients

Table 1 The demographic data of all patients

Diagnosis		Condition (d)	T. Bil	ALT	Cr.	PLT	ICG15D	ICG15E	ICG(K)D	ICG(K)E
1	Alcoholism	Waiting	1.6	121	0.8	16.4	27.2	28.4	0.05	0.08
2	HBV+HCC	Waiting	1.4	47	0.9	12.6	36	38.3	0.03	0.06
3	HBV	During-OLT-(2)	1.6	126	0.8	7.4	3	3.9	0.24	0.22
4	HBV	During-OLT-(2)	1.1	102	1.0	11.8	1	2.5	0.28	0.29
5	HCV+HCC	Post-OLT (43)	0.7	233	2.3	15.1	4	3.7	0.18	0.22
6	HBV	Post-OLT (212)	0.5	8	2.9	12.1	1	2.3	0.35	0.29
7	HBV	Post-OLT (36)	9.1	131	1.6	7.2	26	24	0.10	0.10
		Ac. rejection
8	HBV+HCC	Post-OLT (142)	0.8	15	1.3	11	6.5	6.8	0.21	0.25
9	HBV+HCC	Post-OLT. (166)	1.1	37	0.7	24.9	2	4	0.32	0.23
10	HBV+HCC	Post-OLT (312)	0.5	16	1.0	18.8	4	4.5	0.24	0.21
11	HBV+HCC	Post-OLT (90)	2.0	50	2.2	11.5	18	13.7	0.16	0.13
		Ac. rejection
12	HBV+HCC	Post-OLT (367)	1.3	46	3.4	6.4	10	11.2	0.28	0.27
		Ac. renal failure
13	HBV+HCC	During OLT (1)	3.6	213	3.4	8.5	5.1	5.4	0.31	0.33

HBV: Hepatitis B virus; HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma; OLT: Orthotopic liver transplantation; Ac.: Acute; T. Bil: Total bilirubin; ALT: Alanine aminotransferase; Cr.: Creatinine; PLT: Platelet.

Table 2 The transplanted condition and laboratory data

Patients condition (n)	T. Bil	ICG15D	ICG15E	ICG(K)D	ICG(K)E
ESLD (2)	1.50 ± 0.10	29.6 ± 4.4	34.4 ± 4.9	0.04 ± 0.01	0.07 ± 0.01
During-OLT (3)	1.35 ± 0.25	2.0 ± 1.0	3.2 ± 0.7	0.26 ± 0.02	0.25 ± 0.04
Post-OLT (6)	0.86 ± 0.30	3.6 ± 2.1	3.9 ± 0.8	0.26 ± 0.08	0.24 ± 0.03
Acute rejection (2)	5.60 ± 3.60	22.0 ± 4.0	18.9 ± 5.2	0.13 ± 0.03	0.12 ± 0.02

ESLD: End-stage liver disease on waiting list; During-OLT: immediately after liver transplantation within seven days; Post-OLT: > one month after liver transplantation in stable condition; Acute rejection: proved by liver biopsy; the number in brackets means the case number.